Studies have found that in cervical cancer patients, there is an increase in Tregs over CD8+ T cells, while in head and neck cancer patients, there is a simultaneous increase in both CD8+ T cells and Tregs [45]. This evidence concerns the gene CD8A and head and neck cancer.